查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1300996

皮膚科 CRO 市場規模、份額和趨勢分析報告：按類型、按服務類型、按地區、細分市場趨勢，2023-2030 年

Dermatology CRO Market Size, Share & Trends Analysis Report By Type (Preclinical, Clinical), By Service Type (Laboratory, Regulatory/Medical Affairs), By Region (North America, Asia Pacific), And Segment Forecasts, 2023 - 2030
出版日期: | 出版商: Grand View Research | 英文 175 Pages | 商品交期: 2-10個工作天內

價格

皮膚科 CRO 市場增長和趨勢

GrandView Research, Inc. 的最新報告預測，到 2030 年，全球皮膚科 CRO 市場將達到 80.579 億美元，預測期內復合年增長率為 6.8%。

越來越多的 CRO（合同研究組織）湧入以減少與皮膚病相關的疾病負擔，這是該市場的主要驅動力。 此外，對治療痤瘡的抗感染劑、抗炎劑、局部麻醉劑、潤膚劑和清潔劑等皮膚科外用藥的需求不斷增長，是推動市場增長的主要因素。 對快速診斷的高需求、皮膚癌和其他皮膚病患病率的增加以及對皮膚病認識的提高是推動市場增長的主要因素。

全球皮膚病病例的增加預計將在預測期內推動市場增長。 特應性皮炎是最常見的炎症性皮膚病之一，影響美國約 5-10% 的患者。 此外，皮膚癌是美國□□最常見的癌症。 根據美國皮膚病學會的數據，大約五分之一的人在一生中會患上皮膚癌。 據估計，美國每天約有 9,500 人被診斷患有皮膚癌。 COVID-19疫情對市場產生了重大影響。

包括皮膚科在內的許多治療領域的臨床試驗都受到了 COVID-19 大流行的影響。 多項臨床試驗被暫時推遲或取消，影響了研究進度和進展。 由於皮膚科 CRO 服務與臨床試驗活動密切相關，這種中斷預計將影響皮膚科 CRO 的增長和收入。 此外，皮膚科行業專利到期和研發項目投資增加是預計未來幾年推動市場增長的主要因素。 例如，2022 年 2 月，Recipharm 收購了 CDMO Arranta Bio，以擴大其在美國的 mRNA 生物製劑產品。 此次收購預計將增強公司在癌症、牛皮癬、傳染病等治療領域的藥物開發能力。

皮膚科 CRO 市場報告亮點

  • 按類型劃分，臨床領域將佔銷售額的最大份額，到 2022 年將達到 76.10%。 這是由於臨床試驗的全球化、技術的進步以及對皮膚科 CRO 進行臨床試驗的需求不斷增加。
  • 按服務類型劃分，監管/醫療行業預計將在預測期內佔據較大的市場份額。 新產品審批需求的增加和全球製藥法規的差異是該領域增長的主要驅動力。
  • 2022 年，亞太地區的收入份額將超過 43.29%，位居第一。 這部分是由於人口的多樣性、皮膚病的高患病率、監管框架的改進以及患者招募和保留的便利性。
  • 新冠疫情後臨床試驗的激增為 CRO 進入皮膚科領域提供了利潤豐厚的機會。 例如，2022年1月，Vial通過其子公司Vial Dermatology CRO推出了皮膚科外包服務。 在那裡，我們與美國 35 家皮膚科診所合作，提供更快的臨床試驗。

內容

第一章調查方法及範圍

  • 市場細分和範圍
  • 區域範圍
  • 估計/預測時間表
  • 目的
  • 調查方法
  • 信息獲取
  • 信息或數據分析
  • 市場形成和驗證
  • 型號詳細信息
  • 輔助信息列表
  • 縮寫列表

第 2 章執行摘要

  • 市場前景
  • 分部展望
  • 競爭考慮因素

第 3 章皮膚科 CRO 市場變量、趨勢和範圍

  • 市場體系展望
    • 母公司市場前景
    • 相關/補充市場前景
  • 市場動態
    • 市場驅動因素分析
    • 市場製約因素分析
  • 皮膚科 CRO 市場分析工具
    • 行業分析-波特分析
    • PESTEL 分析
    • COVID-19 感染的影響分析

第 4 章皮膚科 CRO 市場：類型估計和趨勢分析

  • 皮膚科 CRO 市場，按類型：細分儀表板
  • 皮膚科 CRO 市場，按類型：變異分析
    • 藥物發現
    • 臨床前
    • 臨床

第五章皮膚科 CRO 市場：服務類型估算和趨勢分析

  • 皮膚科 CRO 市場，按服務類型劃分：細分儀表板
  • 皮膚科 CRO 市場，按服務類型劃分：變化分析
    • 項目管理/臨床供應管理
    • 數據管理
    • 監管/醫療
    • 醫學寫作
    • 臨床監測
    • 質量控制和保證
    • 生物統計學
    • 向調查人員付款
    • 患者和設施招募
    • 實驗室
    • 技術
    • 其他

第六章皮膚科CRO市場：區域估算和趨勢分析

  • 2022 年和 2030 年區域市場份額分析
  • 區域市場儀表板
  • 全球區域市場概況
  • 北美
    • 2018-2030 年市場預估和預測（收入）
    • 美國
    • 加拿大
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 意大利
    • 西班牙
    • 丹麥
    • 瑞典
    • 挪威
  • 亞太地區
    • 日本
    • 印度
    • 中國
    • 韓國
    • 澳大利亞
    • 泰國
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥倫比亞
    • 智利
  • MEA
    • 南非
    • 沙特阿拉伯
    • 阿拉伯聯合酋長國
    • 以色列
    • 伊朗
    • 科威特

第七章競爭格局

  • 市場進入者分類
    • 創新者
    • 市場領導者
    • 新興玩家
    • 2022 年公司市場份額分析
  • 公司簡介
    • IQVIA, Inc.
    • Labcorp Drug Development
    • Aragen Life Sciences Ltd
    • Pharmaceutical Product Development, Inc.（Thermo Fisher Scientific Inc.）
    • Parexel International Corporation
    • Charles River Laboratories
    • Icon, Plc
    • Medidata
    • Syneos Health
    • S Pharmaron
    • Wuxi Apptec
    • Medpace
    • CTI Clinical Trial &Consulting
    • Bioskin
    • Proinnovera GmbH
    • Biorasi, LLC
    • Javara
    • TFS
Product Code: GVR-4-68039-635-9

Dermatology CRO Market Growth & Trends

The global dermatology CRO market size is expected to reach USD 8,057.9 million by 2030, registering a CAGR of 6.8% over the forecast period, according to a new report by Grand View Research, Inc. Rising influx of contract research organizations (CROs) to mitigate the disease burden associated with dermatological conditions is a key driver for this market. Moreover, the rising demand for topical dermatological medications, such as anti-infective, anti-inflammatory agents, local anesthetics, emollients, and cleansers, to cure acne are major factors driving the market growth. High demand for speedy diagnosis, an increase in the prevalence of skin cancer and other skin problems, and increased awareness regarding skin diseases are major factors boosting the market growth.

An increase in cases of skin disease across the globe is expected to propel the market growth in the forecast period. Atopic dermatitis is one of the most common inflammatory skin diseases, affecting around 5-10% of individuals in the U.S. Around one in three individuals in the country with atopic dermatitis have moderate-to-severe disease. Moreover, skin cancer is the most common cancer in the U.S. According to the American Academy of Dermatology, around 1 in 5 individuals would develop skin cancer in their lifetime. In addition, it is estimated that around 9500 individuals in the country are diagnosed with skin cancer every day. The COVID-19 pandemic significantly impacted the market.

Clinical trials in numerous therapeutic fields, including dermatology, were impacted by the COVID-19 pandemic. Several clinical trials were temporarily delayed or halted, impacting the timelines and progress of research studies. This disruption is expected to affect the growth and revenue of dermatology CROs, as their services are closely tied to clinical trial activities. Furthermore, patent expiration in the dermatology industry and growing investment in R&D programs are key factors anticipated to drive market growth in the coming years. For instance, in February 2022, Recipharm acquired CDMO Arranta Bio to expand its mRNA biologics offerings in the U.S. This acquisition is expected to improve the company's capabilities in developing medications in the area of cancer, psoriasis, infectious diseases, and other diseases.

Dermatology CRO Market Report Highlights

  • Based on type, the clinical segment accounted for the largest revenue share of 76.10% in 2022. This is attributed to the globalization of clinical trials, technological advancements, and an increase in demand for dermatology CROs to conduct clinical trials
  • Based on service type, the regulatory/medical affairs segment is expected to show a significant market share in the forecast period. Increasing demand to obtain approval for new products and differences in drug regulations globally are some of the major factors driving the segment growth
  • Asia Pacific captured the largest revenue share of over 43.29% in 2022. This is due to the diversity in population, high prevalence of skin disorders, improving regulatory framework, and, the ease with which patients may be recruited and retained
  • A post-covid surge in clinical trials provided a lucrative opportunity for CROs to enter the dermatology space. For instance, in January 2022, Vial started providing dermatology outsourcing services via its arm Vial Dermatology CRO. Wherein, they partnered with 35 dermatology clinics in the U.S. to provide faster clinical trials

Table of Content

Chapter 1. Research Methodology And Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Segment Definitions
    • 1.1.2. Type
    • 1.1.3. Service Type
  • 1.2. Regional Scope
  • 1.3. Estimates And Forecast Timeline
  • 1.4. Objectives
    • 1.4.1. Objective - 1
    • 1.4.2. Objective - 2
    • 1.4.3. Objective - 3
  • 1.5. Research Methodology
  • 1.6. Information Procurement
    • 1.6.1. Purchased Database
    • 1.6.2. GVR's Internal Database
    • 1.6.3. Secondary Sources
    • 1.6.4. Primary Research
  • 1.7. Information Or Data Analysis
    • 1.7.1. Data Analysis Models
  • 1.8. Market Formulation & Validation
  • 1.9. Model Details
    • 1.9.1. Commodity Flow Analysis
    • 1.9.2. Parent Market Analysis
  • 1.10. List Of Secondary Sources
  • 1.11. List Of Abbreviations

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. Dermatology CRO Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Increasing adoption of advanced technologies
      • 3.2.1.2. Growing interest to look more appealing
      • 3.2.1.3. Increasing outsourcing of R&D activities
      • 3.2.1.4. Favorable environment for clinical trials in developing countries
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. Quality issues of CRO services
      • 3.2.2.2. Intellectual property rights issues
  • 3.3. Dermatology CRO Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
    • 3.3.3. COVID-19 Impact Analysis

Chapter 4. Dermatology CRO Market: Type Estimates & Trend Analysis

  • 4.1. Dermatology CRO Market, By Type: Segment Dashboard
  • 4.2. Dermatology CRO Market, By Type: Movement Analysis
  • 4.3. Dermatology CRO Market Estimates & Forecasts, By Type, 2018 - 2030
    • 4.3.1. Drug Discovery
      • 4.3.1.1. Drug Discovery Market, 2018 to 2030 (USD Million)
      • 4.3.1.2. Target Validation
      • 4.3.1.2.1. Target Validation Market, 2018 to 2030 (USD Million)
      • 4.3.1.3. Lead Identification
      • 4.3.1.3.1. Lead Identification Market, 2018 to 2030 (USD Million)
      • 4.3.1.4. Lead Optimization
      • 4.3.1.4.1. Lead Optimization Market, 2018 to 2030 (USD Million)
    • 4.3.2. Preclinical
      • 4.3.2.1. Preclinical Market, 2018 to 2030 (USD Million)
    • 4.3.3. Clinical
      • 4.3.3.1. Clinical Market, 2018 to 2030 (USD Million)
      • 4.3.3.2. Phase I
      • 4.3.3.2.1. Phase I Market, 2018 to 2030 (USD Million)
      • 4.3.3.3. Phase II
      • 4.3.3.3.1. Phase II Market, 2018 to 2030 (USD Million)
      • 4.3.3.4. Phase III
      • 4.3.3.4.1. Phase III Market, 2018 to 2030 (USD Million)
      • 4.3.3.5. Phase IV
      • 4.3.3.5.1. Phase IV Market, 2018 to 2030 (USD Million)

Chapter 5. Dermatology CRO Market: Service Type Estimates & Trend Analysis

  • 5.1. Dermatology CRO Market, By Service Type: Segment Dashboard
  • 5.2. Dermatology CRO Market, By Service Type: Movement Analysis
  • 5.3. Dermatology CRO Market Estimates & Forecasts, By Service Type, 2018 - 2030
    • 5.3.1. Project Management/Clinical Supply Management
      • 5.3.1.1. Project Management/Clinical Supply Management Market, 2018 to 2030 (USD Million)
    • 5.3.2. Data Management
      • 5.3.2.1. Data Management Market, 2018 to 2030 (USD Million)
    • 5.3.3. Regulatory/Medical Affairs
      • 5.3.3.1. Regulatory/Medical Affairs Market, 2018 to 2030 (USD Million)
    • 5.3.4. Medical Writing
      • 5.3.4.1. Medical Writing Market, 2018 to 2030 (USD Million)
    • 5.3.5. Clinical Monitoring
      • 5.3.5.1. Clinical Monitoring Market, 2018 to 2030 (USD Million)
    • 5.3.6. Quality Management/ Assurance
      • 5.3.6.1. Quality Management/ Assurance Market, 2018 to 2030 (USD Million)
    • 5.3.7. Bio-statistics
      • 5.3.7.1. Bio-statistics Market, 2018 to 2030 (USD Million)
    • 5.3.8. Investigator Payments
      • 5.3.8.1. Investigator Payments Market, 2018 to 2030 (USD Million)
    • 5.3.9. Laboratory
      • 5.3.9.1. Laboratory Market, 2018 to 2030 (USD Million)
    • 5.3.10. Patient and site Recruitment
      • 5.3.10.1. Patient and site Recruitment Market, 2018 to 2030 (USD Million)
    • 5.3.11. Laboratory
      • 5.3.11.1. Laboratory Market, 2018 to 2030 (USD Million)
    • 5.3.12. Technology
      • 5.3.12.1. Technology Market, 2018 to 2030 (USD Million)
    • 5.3.13. Others
      • 5.3.13.1. Others Market, 2018 to 2030 (USD Million)

Chapter 6. Dermatology CRO Market: Regional Estimates & Trend Analysis

  • 6.1. Regional Market Share Analysis, 2022 & 2030
  • 6.2. Regional Market Dashboard
  • 6.3. Global Regional Market Snapshot
  • 6.4. North America
    • 6.4.1. Market Estimates and Forecast, 2018 - 2030 (Revenue, USD Million)
    • 6.4.2. U.S.
      • 6.4.2.1. Key Country Dynamics
      • 6.4.2.2. Competitive Scenario
      • 6.4.2.3. Regulatory Framework
      • 6.4.2.4. U.S. Market Estimates and Forecasts, 2018 - 2030
    • 6.4.3. Canada
      • 6.4.3.1. Key Country Dynamics
      • 6.4.3.2. Competitive Scenario
      • 6.4.3.3. Regulatory Framework
      • 6.4.3.4. Canada Market Estimates and Forecasts, 2018 - 2030
  • 6.5. Europe
    • 6.5.1. UK
      • 6.5.1.1. Key Country Dynamics
      • 6.5.1.2. Competitive Scenario
      • 6.5.1.3. Regulatory Framework
      • 6.5.1.4. UK Market Estimates and Forecasts, 2018 - 2030
    • 6.5.2. Germany
      • 6.5.2.1. Key Country Dynamics
      • 6.5.2.2. Competitive Scenario
      • 6.5.2.3. Regulatory Framework
      • 6.5.2.4. Germany Market Estimates and Forecasts, 2018 - 2030
    • 6.5.3. France
      • 6.5.3.1. Key Country Dynamics
      • 6.5.3.2. Competitive Scenario
      • 6.5.3.3. Regulatory Framework
      • 6.5.3.4. France Market Estimates and Forecasts, 2018 - 2030
    • 6.5.4. Italy
      • 6.5.4.1. Key Country Dynamics
      • 6.5.4.2. Competitive Scenario
      • 6.5.4.3. Regulatory Framework
      • 6.5.4.4. Italy Market Estimates and Forecasts, 2018 - 2030
    • 6.5.5. Spain
      • 6.5.5.1. Key Country Dynamics
      • 6.5.5.2. Competitive Scenario
      • 6.5.5.3. Regulatory Framework
      • 6.5.5.4. Spain Market Estimates and Forecasts, 2018 - 2030
    • 6.5.6. Denmark
      • 6.5.6.1. Key Country Dynamics
      • 6.5.6.2. Competitive Scenario
      • 6.5.6.3. Regulatory Framework
      • 6.5.6.4. Denmark Market Estimates and Forecasts, 2018 - 2030
    • 6.5.7. Sweden
      • 6.5.7.1. Key Country Dynamics
      • 6.5.7.2. Competitive Scenario
      • 6.5.7.3. Regulatory Framework
      • 6.5.7.4. Sweden Market Estimates and Forecasts, 2018 - 2030
    • 6.5.8. Norway
      • 6.5.8.1. Key Country Dynamics
      • 6.5.8.2. Competitive Scenario
      • 6.5.8.3. Regulatory Framework
      • 6.5.8.4. Norway Market Estimates and Forecasts, 2018 - 2030
  • 6.6. Asia Pacific
    • 6.6.1. Japan
      • 6.6.1.1. Key Country Dynamics
      • 6.6.1.2. Competitive Scenario
      • 6.6.1.3. Regulatory Framework
      • 6.6.1.4. Japan Market Estimates and Forecasts, 2018 - 2030
    • 6.6.2. India
      • 6.6.2.1. Key Country Dynamics
      • 6.6.2.2. Competitive Scenario
      • 6.6.2.3. Regulatory Framework
      • 6.6.2.4. India Market Estimates and Forecasts, 2018 - 2030
    • 6.6.3. China
      • 6.6.3.1. Key Country Dynamics
      • 6.6.3.2. Competitive Scenario
      • 6.6.3.3. Regulatory Framework
      • 6.6.3.4. China Market Estimates and Forecasts, 2018 - 2030
    • 6.6.4. South Korea
      • 6.6.4.1. Key Country Dynamics
      • 6.6.4.2. Competitive Scenario
      • 6.6.4.3. Regulatory Framework
      • 6.6.4.4. South Korea Market Estimates and Forecasts, 2018 - 2030
    • 6.6.5. Australia
      • 6.6.5.1. Key Country Dynamics
      • 6.6.5.2. Competitive Scenario
      • 6.6.5.3. Regulatory Framework
      • 6.6.5.4. Australia Market Estimates and Forecasts, 2018 - 2030
    • 6.6.6. Thailand
      • 6.6.6.1. Key Country Dynamics
      • 6.6.6.2. Competitive Scenario
      • 6.6.6.3. Regulatory Framework
      • 6.6.6.4. Thailand Market Estimates and Forecasts, 2018 - 2030
  • 6.7. Latin America
    • 6.7.1. Brazil
      • 6.7.1.1. Key Country Dynamics
      • 6.7.1.2. Competitive Scenario
      • 6.7.1.3. Regulatory Framework
      • 6.7.1.4. Brazil Market Estimates and Forecasts, 2018 - 2030
    • 6.7.2. Mexico
      • 6.7.2.1. Key Country Dynamics
      • 6.7.2.2. Competitive Scenario
      • 6.7.2.3. Regulatory Framework
      • 6.7.2.4. Mexico Market Estimates and Forecasts, 2018 - 2030
    • 6.7.3. Argentina
      • 6.7.3.1. Key Country Dynamics
      • 6.7.3.2. Competitive Scenario
      • 6.7.3.3. Regulatory Framework
      • 6.7.3.4. Argentina Market Estimates and Forecasts, 2018 - 2030
    • 6.7.4. Colombia
      • 6.7.4.1. Key Country Dynamics
      • 6.7.4.2. Competitive Scenario
      • 6.7.4.3. Regulatory Framework
      • 6.7.4.4. Colombia Market Estimates and Forecasts, 2018 - 2030
    • 6.7.5. Chile
      • 6.7.5.1. Key Country Dynamics
      • 6.7.5.2. Competitive Scenario
      • 6.7.5.3. Regulatory Framework
      • 6.7.5.4. Chile Market Estimates and Forecasts, 2018 - 2030
  • 6.8. MEA
    • 6.8.1. South Africa
      • 6.8.1.1. Key Country Dynamics
      • 6.8.1.2. Competitive Scenario
      • 6.8.1.3. Regulatory Framework
      • 6.8.1.4. South Africa Market Estimates and Forecasts, 2018 - 2030
    • 6.8.2. Saudi Arabia
      • 6.8.2.1. Key Country Dynamics
      • 6.8.2.2. Competitive Scenario
      • 6.8.2.3. Regulatory Framework
      • 6.8.2.4. Saudi Arabia Market Estimates and Forecasts, 2018 - 2030
    • 6.8.3. UAE
      • 6.8.3.1. Key Country Dynamics
      • 6.8.3.2. Competitive Scenario
      • 6.8.3.3. Regulatory Framework
      • 6.8.3.4. UAE Market Estimates and Forecasts, 2018 - 2030
    • 6.8.4. Israel
      • 6.8.4.1. Key Country Dynamics
      • 6.8.4.2. Competitive Scenario
      • 6.8.4.3. Regulatory Framework
      • 6.8.4.4. Israel Market Estimates and Forecasts, 2018 - 2030
    • 6.8.5. Iran
      • 6.8.5.1. Key Country Dynamics
      • 6.8.5.2. Competitive Scenario
      • 6.8.5.3. Regulatory Framework
      • 6.8.5.4. Iran Market Estimates and Forecasts, 2018 - 2030
    • 6.8.6. Kuwait
      • 6.8.6.1. Key Country Dynamics
      • 6.8.6.2. Competitive Scenario
      • 6.8.6.3. Regulatory Framework
      • 6.8.6.4. Kuwait Market Estimates and Forecasts, 2018 - 2030

Chapter 7. Competitive Landscape

  • 7.1. Market Participant Categorization
    • 7.1.1. Innovators
    • 7.1.2. Market Leaders
    • 7.1.3. Emerging Players
    • 7.1.4. Company Market Share Analysis, 2022
  • 7.2. Company Profiles
    • 7.2.1. IQVIA, Inc.
      • 7.2.1.1. Company Overview
      • 7.2.1.2. Financial Performance
      • 7.2.1.3. Service Benchmarking
      • 7.2.1.4. Strategic Initiatives
    • 7.2.2. Labcorp Drug Development
      • 7.2.2.1. Company Overview
      • 7.2.2.2. Financial Performance
      • 7.2.2.3. Service Benchmarking
      • 7.2.2.4. Strategic Initiatives
    • 7.2.3. Aragen Life Sciences Ltd
      • 7.2.3.1. Company Overview
      • 7.2.3.2. Financial Performance
      • 7.2.3.3. Service Benchmarking
      • 7.2.3.4. Strategic Initiatives
    • 7.2.4. Pharmaceutical Product Development, Inc. (Thermo Fisher Scientific Inc.)
      • 7.2.4.1. Company Overview
      • 7.2.4.2. Financial Performance
      • 7.2.4.3. Service Benchmarking
      • 7.2.4.4. Strategic Initiatives
    • 7.2.5. Parexel International Corporation
      • 7.2.5.1. Company Overview
      • 7.2.5.2. Financial Performance
      • 7.2.5.3. Service Benchmarking
      • 7.2.5.4. Strategic Initiatives
    • 7.2.6. Charles River Laboratories
      • 7.2.6.1. Company Overview
      • 7.2.6.2. Financial Performance
      • 7.2.6.3. Service Benchmarking
      • 7.2.6.4. Strategic Initiatives
    • 7.2.7. Icon, Plc
      • 7.2.7.1. Company Overview
      • 7.2.7.2. Financial Performance
      • 7.2.7.3. Service Benchmarking
      • 7.2.7.4. Strategic Initiatives
    • 7.2.8. Medidata
      • 7.2.8.1. Company Overview
      • 7.2.8.2. Financial Performance
      • 7.2.8.3. Service Benchmarking
      • 7.2.8.4. Strategic Initiatives.
    • 7.2.9. Syneos Health
      • 7.2.9.1. Company Overview
      • 7.2.9.2. Financial Performance
      • 7.2.9.3. Service Benchmarking
      • 7.2.9.4. Strategic Initiatives
    • 7.2.10. S Pharmaron
      • 7.2.10.1. Company Overview
      • 7.2.10.2. Financial Performance
      • 7.2.10.3. Service Benchmarking
      • 7.2.10.4. Strategic Initiatives
    • 7.2.11. Wuxi Apptec
      • 7.2.11.1. Company Overview
      • 7.2.11.2. Financial Performance
      • 7.2.11.3. Service Benchmarking
      • 7.2.11.4. Strategic Initiatives
    • 7.2.12. Medpace
      • 7.2.12.1. Company Overview
      • 7.2.12.2. Financial Performance
      • 7.2.12.3. Service Benchmarking
      • 7.2.12.4. Strategic Initiatives
      • 7.2.12.5. CTI Clinical Trial & Consulting
    • 7.2.13. CTI Clinical Trial & Consulting
      • 7.2.13.1. Company Overview
      • 7.2.13.2. Financial Performance
      • 7.2.13.3. Service Benchmarking
      • 7.2.13.4. Strategic Initiatives
    • 7.2.14. Bioskin
      • 7.2.14.1. Company Overview
      • 7.2.14.2. Financial Performance
      • 7.2.14.3. Service Benchmarking
      • 7.2.14.4. Strategic Initiatives
    • 7.2.15. Proinnovera GmbH
      • 7.2.15.1. Company Overview
      • 7.2.15.2. Financial Performance
      • 7.2.15.3. Service Benchmarking
      • 7.2.15.4. Strategic Initiatives
    • 7.2.16. Biorasi, LLC
      • 7.2.16.1. Company Overview
      • 7.2.16.2. Financial Performance
      • 7.2.16.3. Service Benchmarking
      • 7.2.16.4. Strategic Initiatives
    • 7.2.17. Javara
      • 7.2.17.1. Company Overview
      • 7.2.17.2. Financial Performance
      • 7.2.17.3. Service Benchmarking
      • 7.2.17.4. Strategic Initiatives
    • 7.2.18. TFS
      • 7.2.18.1. Company Overview
      • 7.2.18.2. Financial Performance
      • 7.2.18.3. Service Benchmarking
      • 7.2.18.4. Strategic Initiatives

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of Abbreviations
  • Table 3 North America Dermatology CRO Market, By Region, 2018 - 2030 (USD Million)
  • Table 4 North America Dermatology CRO Market, By Type, 2018 - 2030 (USD Million)
  • Table 5 North America Dermatology CRO Market, By Service Type, 2018 - 2030 (USD Million)
  • Table 6 U.S. Dermatology CRO Market, By Type, 2018 - 2030 (USD Million)
  • Table 7 U.S. Dermatology CRO Market, By Service Type, 2018 - 2030 (USD Million)
  • Table 8 Canada Dermatology CRO Market, By Type, 2018 - 2030 (USD Million)
  • Table 9 Canada Dermatology CRO Market, By Service Type, 2018 - 2030 (USD Million)
  • Table 10 Europe Dermatology CRO Market, By Region, 2018 - 2030 (USD Million)
  • Table 11 Europe Dermatology CRO Market, By Type, 2018 - 2030 (USD Million)
  • Table 12 Europe Dermatology CRO Market, By Service Type, 2018 - 2030 (USD Million)
  • Table 13 UK Dermatology CRO Market, By Type, 2018 - 2030 (USD Million)
  • Table 14 UK Dermatology CRO Market, By Service Type, 2018 - 2030 (USD Million)
  • Table 15 Germany Dermatology CRO Market, By Type, 2018 - 2030 (USD Million)
  • Table 16 Germany Dermatology CRO Market, By Service Type, 2018 - 2030 (USD Million)
  • Table 17 France Dermatology CRO Market, By Type, 2018 - 2030 (USD Million)
  • Table 18 France Dermatology CRO Market, By Service Type, 2018 - 2030 (USD Million)
  • Table 19 Italy Dermatology CRO Market, By Type, 2018 - 2030 (USD Million)
  • Table 20 Italy Dermatology CRO Market, By Service Type, 2018 - 2030 (USD Million)
  • Table 21 Spain Dermatology CRO Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 22 Spain Dermatology CRO Market, By Service Type, 2018 - 2030 (USD Million)
  • Table 23 Denmark Dermatology CRO Market, By Type, 2018 - 2030 (USD Million)
  • Table 24 Denmark Dermatology CRO Market, By Service Type, 2018 - 2030 (USD Million)
  • Table 25 Sweden Dermatology CRO Market, By Type, 2018 - 2030 (USD Million)
  • Table 26 Sweden Dermatology CRO Market, By Service Type, 2018 - 2030 (USD Million)
  • Table 27 Norway Dermatology CRO Market, By Type, 2018 - 2030 (USD Million)
  • Table 28 Norway Dermatology CRO Market, By Service Type, 2018 - 2030 (USD Million)
  • Table 29 Asia Pacific Dermatology CRO Market, By Region, 2018 - 2030 (USD Million)
  • Table 30 Asia Pacific Dermatology CRO Market, By Type, 2018 - 2030 (USD Million)
  • Table 31 Asia Pacific Dermatology CRO Market, By Service Type, 2018 - 2030 (USD Million)
  • Table 32 China Dermatology CRO Market, By Type, 2018 - 2030 (USD Million)
  • Table 33 China Dermatology CRO Market, By Service Type, 2018 - 2030 (USD Million)
  • Table 34 Japan Dermatology CRO Market, By Type, 2018 - 2030 (USD Million)
  • Table 35 Japan Dermatology CRO Market, By Service Type, 2018 - 2030 (USD Million)
  • Table 36 India Dermatology CRO Market, By Type, 2018 - 2030 (USD Million)
  • Table 37 India Dermatology CRO Market, By Service Type, 2018 - 2030 (USD Million)
  • Table 38 Australia Dermatology CRO Market, By Type, 2018 - 2030 (USD Million)
  • Table 39 Australia Dermatology CRO Market, By Service Type, 2018 - 2030 (USD Million)
  • Table 40 South Korea Dermatology CRO Market, By Type, 2018 - 2030 (USD Million)
  • Table 41 South Korea Dermatology CRO Market, By Service Type, 2018 - 2030 (USD Million)
  • Table 42 Thailand Dermatology CRO Market, By Type, 2018 - 2030 (USD Million)
  • Table 43 Thailand Dermatology CRO Market, By Service Type, 2018 - 2030 (USD Million)
  • Table 44 Latin America Dermatology CRO Market, By Region, 2018 - 2030 (USD Million)
  • Table 45 Latin America Dermatology CRO Market, By Type, 2018 - 2030 (USD Million)
  • Table 46 Latin America Dermatology CRO Market, By Service Type, 2018 - 2030 (USD Million)
  • Table 47 Brazil Dermatology CRO Market, By Type, 2018 - 2030 (USD Million)
  • Table 48 Brazil Dermatology CRO Market, By Service Type, 2018 - 2030 (USD Million)
  • Table 49 Mexico Dermatology CRO Market, By Type, 2018 - 2030 (USD Million)
  • Table 50 Mexico Dermatology CRO Market, By Service Type, 2018 - 2030 (USD Million)
  • Table 51 Argentina Dermatology CRO Market, By Type, 2018 - 2030 (USD Million)
  • Table 52 Argentina Dermatology CRO Market, By Service Type, 2018 - 2030 (USD Million)
  • Table 53 Colombia Dermatology CRO Market, By Type, 2018 - 2030 (USD Million)
  • Table 54 Colombia Dermatology CRO Market, By Service Type, 2018 - 2030 (USD Million)
  • Table 55 Chile Dermatology CRO Market, By Type, 2018 - 2030 (USD Million)
  • Table 56 Chile Dermatology CRO Market, By Service Type, 2018 - 2030 (USD Million)
  • Table 57 Middle East And Africa Dermatology CRO Market, By Region, 2018 - 2030 (USD Million)
  • Table 58 Middle East And Africa Dermatology CRO Market, By Type, 2018 - 2030 (USD Million)
  • Table 59 Middle East And Africa Dermatology CRO Market, By Service Type, 2018 - 2030 (USD Million)
  • Table 60 South Africa Dermatology CRO Market, By Type, 2018 - 2030 (USD Million)
  • Table 61 South Africa Dermatology CRO Market, By Service Type, 2018 - 2030 (USD Million)
  • Table 62 Saudi Arabia Dermatology CRO Market, By Type, 2018 - 2030 (USD Million)
  • Table 63 Saudi Arabia Dermatology CRO Market, By Service Type, 2018 - 2030 (USD Million)
  • Table 64 UAE Dermatology CRO Market, By Type, 2018 - 2030 (USD Million)
  • Table 65 UAE Dermatology CRO Market, By Service Type, 2018 - 2030 (USD Million)
  • Table 66 Iran Dermatology CRO Market, By Type, 2018 - 2030 (USD Million)
  • Table 67 Iran Dermatology CRO Market, By Service Type, 2018 - 2030 (USD Million)
  • Table 68 Israel Dermatology CRO Market, By Type, 2018 - 2030 (USD Million)
  • Table 69 Israel Dermatology CRO Market, By Service Type, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Information Procurement
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value chain based sizing & forecasting
  • Fig. 6 QFD modelling for market share assessment
  • Fig. 7 Market segmentation & scope
  • Fig. 8 Dermatology CRO market outlook, 2018 - 2030
  • Fig. 9 Market trends & outlook
  • Fig. 10 Penetration & growth prospect mapping by service, 2022
  • Fig. 11 Market driver relevance analysis (Current & future impact)
  • Fig. 12 Market restraint relevance analysis (Current & future impact)
  • Fig. 13 SWOT Analysis, By factor (political & legal, economic and technological)
  • Fig. 14 Porter's five forces analysis
  • Fig. 16 Global dermatology CRO market: Type movement analysis
  • Fig. 17 Drug discovery market 2018 - 2030 (USD Million)
  • Fig. 18 Target validation market 2018 - 2030 (USD Million)
  • Fig. 19 Lead identification market 2018 - 2030 (USD Million)
  • Fig. 20 Lead optimization market 2018 - 2030 (USD Million)
  • Fig. 21 Preclinical market 2018 - 2030 (USD Million)
  • Fig. 22 Clinical market 2018 - 2030 (USD Million)
  • Fig. 23 Phase I market 2018 - 2030 (USD Million)
  • Fig. 24 Phase II market 2018 - 2030 (USD Million)
  • Fig. 25 Phase III market 2018 - 2030 (USD Million)
  • Fig. 26 Phase IV market 2018 - 2030 (USD Million)
  • Fig. 27 Global dermatology CRO market: Service Type movement analysis
  • Fig. 28 Project management/clinical supply management market 2018 - 2030 (USD Million)
  • Fig. 29 Data management market 2018 - 2030 (USD Million)
  • Fig. 30 Regulatory/medical affairs market 2018 - 2030 (USD Million)
  • Fig. 31 Medical writing market 2018 - 2030 (USD Million)
  • Fig. 32 Clinical monitoring market 2018 - 2030 (USD Million)
  • Fig. 33 Quality management/ assurance market 2018 - 2030 (USD Million)
  • Fig. 34 Bio-statistics market 2018 - 2030 (USD Million)
  • Fig. 35 Investigator payments market 2018 - 2030 (USD Million)
  • Fig. 36 Laboratory market 2018 - 2030 (USD Million)
  • Fig. 37 Patient and site recruitment market 2018 - 2030 (USD Million)
  • Fig. 38 Technology market 2018 - 2030 (USD Million)
  • Fig. 39 Others market 2018 - 2030 (USD Million)
  • Fig. 40 Regional market place: Key takeaway
  • Fig. 41 Dermatology CRO regional outlook, 2022 & 2030
  • Fig. 42 North America dermatology CRO market, 2018 - 2030 (USD Million)
  • Fig. 43 U.S. dermatology CRO market, 2018 - 2030 (USD Million)
  • Fig. 44 Canada dermatology CRO market, 2018 - 2030 (USD Million)
  • Fig. 45 Europe dermatology CRO market, 2018 - 2030 (USD Million)
  • Fig. 46 Germany dermatology CRO market, 2018 - 2030 (USD Million)
  • Fig. 47 France dermatology CRO market, 2018 - 2030 (USD Million)
  • Fig. 48 UK dermatology CRO market, 2018 - 2030 (USD Million)
  • Fig. 49 Spain dermatology CRO market, 2018 - 2030 (USD Million)
  • Fig. 50 Italy dermatology CRO market, 2018 - 2030 (USD Million)
  • Fig. 51 Sweden dermatology CRO market, 2018 - 2030 (USD Million)
  • Fig. 52 Denmark dermatology CRO market, 2018 - 2030 (USD Million)
  • Fig. 53 Norway dermatology CRO market, 2018 - 2030 (USD Million)
  • Fig. 54 Asia Pacific dermatology CRO market, 2018 - 2030 (USD Million)
  • Fig. 55 China dermatology CRO market, 2018 - 2030 (USD Million)
  • Fig. 56 Japan dermatology CRO market, 2018 - 2030 (USD Million)
  • Fig. 57 India dermatology CRO market, 2018 - 2030 (USD Million)
  • Fig. 58 Australia dermatology CRO market, 2018 - 2030 (USD Million)
  • Fig. 59 South Korea dermatology CRO market, 2018 - 2030 (USD Million)
  • Fig. 59 Thailand dermatology CRO market, 2018 - 2030 (USD Million)
  • Fig. 60 Latin America dermatology CRO market, 2018 - 2030 (USD Million)
  • Fig. 61 Brazil dermatology CRO market, 2018 - 2030 (USD Million)
  • Fig. 62 Mexico dermatology CRO market, 2018 - 2030 (USD Million)
  • Fig. 63 Argentina dermatology CRO market, 2018 - 2030 (USD Million)
  • Fig. 64 Colombia dermatology CRO market, 2018 - 2030 (USD Million)
  • Fig. 65 Chile dermatology CRO market, 2018 - 2030 (USD Million)
  • Fig. 66 Middle East & Africa Dermatology CRO Market, 2018 - 2030 (USD Million)
  • Fig. 67 South Africa Dermatology CRO Market, 2018 - 2030 (USD Million)
  • Fig. 68 Saudi Arabia Dermatology CRO Market, 2018 - 2030 (USD Million)
  • Fig. 69 UAE Dermatology CRO Market, 2018 - 2030 (USD Million)
  • Fig. 70 Israel Arabia Dermatology CRO Market, 2018 - 2030 (USD Million)
  • Fig. 71 Iran Dermatology CRO Market, 2018 - 2030 (USD Million)
  • Fig. 72 Kuwait Dermatology CRO Market, 2018 - 2030 (USD Million)